文献速递白内障与屈光手术

无足够囊膜支撑无晶状体眼三种人工晶状体植入术式网状Meta分析

Comparison of Three Intraocular Lens Implantation Procedures for Aphakic Eyes With Insufficient Capsular Support: A Network Meta-analysis.
PubMed 文献 · Am J Ophthalmol · 2018-05-08

该系统综述与网状Meta分析检索PubMed、EMBASE和Cochrane图书馆截至2017年4月的文献,纳入14项研究共845眼,比较经巩膜固定、巩膜内固定与虹膜固定人工晶状体植入的视力结局与并发症。三种术式最佳矫正视力及达到20/40或更好比例无显著差异,但并发症风险不同:虹膜固定眼内出血和青光眼升级风险较低、手术时间较短,但角膜内皮损害更明显。

要点

  • 三种术式最佳矫正视力及达到20/40或更好比例无显著差异。
  • 虹膜固定眼内出血风险低于巩膜内固定和经巩膜固定,手术时间更短。
  • 虹膜固定较经巩膜固定角膜内皮细胞密度损害和内皮细胞丢失率更高。

核心结论

  • 对于囊膜支撑不足的眼,经巩膜固定、巩膜内固定与虹膜固定植入人工晶状体术后视力结局相当,但部分并发症风险存在差异。
  • 虹膜固定在眼内出血和青光眼升级风险较低及手术时间较短方面占优,但在内皮细胞损害较大方面处于劣势。
  • 由于部分患者可能对某种术式有明确禁忌,术式选择最终取决于术者经验和患者具体病变。

研究设计与样本

  • 系统综述与网状Meta分析,检索PubMed、EMBASE和Cochrane图书馆截至2017年4月、无语言限制的相关文献。
  • 共纳入14项研究、845眼,采用贝叶斯框架比较三种术式的视力结局与并发症。

主要发现

  • 任意两种术式间最佳矫正视力及最终最佳矫正视力达到20/40或更好(Snellen)的比例均无显著差异。
  • 巩膜内固定较经巩膜固定囊样黄斑水肿风险更低(RR 0.45,95%CI 0.18至1.0)。
  • 虹膜固定眼内出血风险低于巩膜内固定(RR 0.078,95%CI 0.0095至0.38),也低于经巩膜固定(RR 0.26,95%CI 0.09至0.72)。
  • 虹膜固定青光眼升级风险较低,差异略高于常规显著性水平(RR 0.41,95%CI 0.16至1.04)。
  • 虹膜固定手术时间短于经巩膜固定(SMD -2.98,95%CI -4.32至-1.64)和巩膜内固定(SMD -2.60,95%CI -3.71至-1.49)。

关键数值与推荐

  • 纳入标准为符合 eligibility criteria 的相关研究,共14项研究、845眼。
  • 巩膜内固定较经巩膜固定囊样黄斑水肿风险:RR 0.45,95%CI 0.18至1.0。
  • 虹膜固定较巩膜内固定眼内出血风险:RR 0.078,95%CI 0.0095至0.38;虹膜固定较经巩膜固定:RR 0.26,95%CI 0.09至0.72。
  • 虹膜固定青光眼升级风险:RR 0.41,95%CI 0.16至1.04。
  • 手术时间:虹膜固定较经巩膜固定SMD -2.98,95%CI -4.32至-1.64;虹膜固定较巩膜内固定SMD -2.60,95%CI -3.71至-1.49。

临床怎么用

  • 作者认为,对于囊膜支撑不足的眼,三种术式术后视力结局相当,但部分并发症风险存在差异。
  • 作者指出,由于部分患者可能对某种术式有明确禁忌,术式选择最终取决于术者经验和患者具体病变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare the clinical outcomes and main complications of transscleral-fixated (TSF), intrascleral-fixated (ISF), and iris-fixated (IF) intraocular lenses (IOLs). DESIGN: Systematic review and network meta-analysis. METHODS: The authors searched PubMed, EMBASE, and the Cochrane Library for relevant articles up to April 2017 with no language restrictions, and related studies meeting the eligibility criteria were included. A Bayesian framework was applied to compare the visual outcomes and complications of these 3 approaches. RESULTS: A total of 14 studies with 845 eyes were included in the present report. There was no significant difference between any pair of surgical approaches in best-corrected visual acuity (BCVA) and in final BCVA achieving 20/40 or better (Snellen). ISF presented a lower risk of cystoid macular edema (CME) compared with TSF (risk ratio [RR], 0.45; 95% confidence interval [CI], [0.18, 1.0]). IF showed superiorities in less intraocular hemorrhage (IOH) than ISF (RR, 0.078; 95% CI [0.0095, 0.38]), as well as TSF (RR, 0.26; 95% CI, [0.09, 0.72]). IF had a lower risk of glaucoma escalation; the difference was slightly higher than the conventional level of significance (RR, 0.41; 95% CI, [0.16, 1.04]). Moreover, the surgical time in IF was shorter than TSF (standard mean difference [SMD], -2.98; 95% CI, [-4.32, -1.64]) and ISF (SMD, -2.60; 95% CI, [-3.71, -1.49]). However, IF was associated with a significantly higher risk of endothelial cell density (ECD) impairment (SMD, -0.54; 95% CI, [-1.02, -0.05]) and significantly greater postoperative corneal endothelial cell loss rate (ECLR, %) (SMD, 0.35; 95% CI, [0.08, 0.63]) compared with TSF. CONCLUSIONS: Postoperative visual outcomes were comparable among TSF, ISF, and IF for eyes with insufficient capsular support. However, the risk of some complications differed among approaches. IF showed its superiorities in lower risk of IOH and glaucoma escalation as well as shorter surgical time, while IF was at a disadvantage in greater endothelial cell impairment. Since some patients might have a clear contraindication to one of the surgical approaches, the decision of surgical approach eventually depends on surgeon experience and the presenting pathology.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Li X, Ni S, Li S, et al. Comparison of Three Intraocular Lens Implantation Procedures for Aphakic Eyes With Insufficient Capsular Support: A Network Meta-analysis. Am J Ophthalmol. 2018. PMID: 29750951. doi:10.1016/j.ajo.2018.04.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。